Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avrio Appoints Quality/Regulatory Affairs VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Avrio Appoints Quality/Regulatory Affairs VP

Jones brings 25 years of experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Laura Jones, Ph.D., has been appointed vice president of quality and regulatory affairs at Avrio Biopharmaceuticals. Dr. Jones will be responsible for leading and overseeing Avrio’s quality and regulatory compliance systems.
 
“With more than 25 years of experience in the pharmaceutical and biopharmaceutical industries, Laura offers a wealth of knowledge and experience in quality assurance and regulatory affairs,” said William Botha, president of Avrio Biopharma. “I am confident knowing that Laura’s in-depth expertise will even further enhance Avrio’s robust quality systems to continuously improve the quality of service Avrio provides its clients.”
 
Dr. Jones has served quality assurance and regulatory affairs management roles supporting the pharmaceutical, biopharmaceutical, and medical device industries. Dr. Jones joins the company from Bayer HealthCare, where she served as quality assurance director. Prior to Bayer, she held leadership roles at Valeant Pharmaceuticals International, Inc. (PII), Medtronic, Elan Pharmaceuticals, and Amphastar Pharmaceuticals.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics